ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 391 - 405 of 5508 products
Arctic Vision Starts China Phase III Trial of Farsightedness Therapy
$5.00
Available
ClinChoice, a Global Clinical CRO, Raises $150 Million from China Investors
$5.00
Available
Brii Bio In-licenses China Rights to Second HBV mAb from Vir
$5.00
Available
Ascletis Says PD-L1 Induces “Functional Cure” in CHB Patients
$5.00
Available
Clover Bio’s COVID Vaccine Effective as Booster Against Omicron Variants
$5.00
Available
BeiGene’s Phase III Data Shows PD-1 Effective as First Line Therapy for Esophageal Carcinoma
$5.00
Available
Suzhou Ascentage to Start US Trial of Novel EED Protein Inhibitor
$5.00
Available
Akeso Approved to Launch Dual Checkpoint Inhibitor for Cervical Cancer
$5.00
Available
GenFleet to Receive Royalty Rights for Conducting China Trial of BioLineRx Cancer Drug
$5.00
Available
Henlius Acquires Two Novel Immunotherapy Candidates in $196.5 Million Deal
$5.00
Available
Shanghai Zai Lab Raises Hong Kong Listing to Primary Status
$5.00
Available
Innovent/Lilly Announce China Approval for Sixth Indication of PD-1 Drug
$5.00
Available
Harbour BioMed to Start US Trials of Novel Bispecific for Solid Tumor Cancers
$5.00
Available
Reistone Completes $100 Million A Round for Inflammatory Disease Drugs
$5.00
Available
Genor Partners with Abogen to Develop mRNA Products for Oncology Needs
$5.00
Available